Biomarin Pharmaceutical (BMRN) Accumulated Expenses (2010 - 2015)
Biomarin Pharmaceutical's Accumulated Expenses was $109.63 million in Q2 2015, up 38.2% from $79.34 million a year earlier and up 3.0% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Accumulated Expenses (2010 - 2015) Analysis & Trends
At the end of FY2014, Accumulated Expenses at Biomarin Pharmaceutical came in at $98.49 million, up 68.6% from FY2013.
- Accumulated Expenses has now increased for three consecutive years, with a four-year compound annual growth rate of 41.7% (FY2010 to FY2014).
- In earlier years, Accumulated Expenses was $58.41 million in FY2013 (+35.3%), $43.16 million in FY2012 (+81.0%), $23.85 million in FY2011 (-2.3%) and $24.41 million in FY2010.
- The Q2 2015 figure marks the highest quarterly Accumulated Expenses in data going back to Q4 2010.
- Compared with a year earlier, Accumulated Expenses has increased for three straight quarters, with growth averaging 52.3% over the last seven quarters.
- The best year-over-year quarter for Accumulated Expenses over five years was Q3 2012 (growth of 100.1%); the worst was Q4 2011 (a decline of 2.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 109.63 Mn |
| Mar 31, 2015 | 106.46 Mn |
| Dec 31, 2014 | 98.49 Mn |
| Jun 30, 2014 | 79.34 Mn |
| Mar 31, 2014 | 64.40 Mn |
| Dec 31, 2013 | 58.41 Mn |
| Sep 30, 2013 | 58.67 Mn |
| Jun 30, 2013 | 52.10 Mn |
| Mar 31, 2013 | 44.34 Mn |
| Dec 31, 2012 | 43.16 Mn |
| Sep 30, 2012 | 36.39 Mn |
| Jun 30, 2012 | 32.45 Mn |
| Mar 31, 2012 | 26.98 Mn |
| Dec 31, 2011 | 23.85 Mn |
| Sep 30, 2011 | 18.18 Mn |
| Jun 30, 2011 | 19.92 Mn |
| Dec 31, 2010 | 24.41 Mn |
API Access
Biomarin Pharmaceutical Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();